Healio

FDA approves subcutaneous, self-administered furosemide for congestion in chronic HF

Please provide your email address to receive an email when new articles are posted on . scPharmaceuticals Inc. announced the FDA approved its self-administered subcutaneous furosemide injection for ...
Medscape

FDA Approves Self-administered, SubQ Furosemide Preparation

The US Food and Drug Administration (FDA) has approved a furosemide preparation (Furoscix, scPharmaceuticals) intended for subcutaneous self-administration by outpatients with chronic heart failure ...
Hosted on MSN

New delivery method lets cancer patients skip IVs, self-inject protein drugs at home

Patients with cancer, autoimmune diseases, and metabolic disorders often endure hours-long intravenous infusions. These treatments involve protein-based drugs, which must be given in high doses but ...
Pharmabiz

AstraZeneca announces Saphnelo self-administration phase III TULIP-SC trial demonstrates statistically significant and clinically meaningful reduction in SLE disease activity

AstraZeneca announces Saphnelo self-administration phase III TULIP-SC trial demonstrates statistically significant and clinically meaningful reduction in SLE disease activity: Cam ...